Stonebridge Capital Advisors’s St Jude Medical STJ Stock Holding History

Stonebridge Capital Advisors’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,914	Closed	-$232K	–	172
2016 Q3	$232K	Sell	2,914 -1,100	-27%	-$88.8K	0.07%	137
2016 Q2	$313K	Buy	+4,014	New	+$286K	0.11%	118
2015 Q3	–	Sell	-3,360	Closed	-$246K	–	157
2015 Q2	$246K	Buy	3,360 +135	+4%	+$9.75K	0.09%	130
2015 Q1	$211K	Hold	3,225	–	–	0.08%	140
2014 Q4	$210K	Buy	+3,225	New	+$208K	0.09%	137
2014 Q3	–	Sell	-3,225	Closed	-$224K	–	155
2014 Q2	$224K	Hold	3,225	–	–	0.1%	131
2014 Q1	$211K	Sell	3,225 -100	-3%	-$6.51K	0.1%	130
2013 Q4	$206K	Buy	+3,325	New	+$193K	0.11%	127

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Stonebridge Capital Advisors's STJ Position: Q4 2016 in Review

Stonebridge Capital Advisors sold out of St Jude Medical (STJ) in Q4 2016, closing a stake of 2,914 shares — an estimated $232K sold.

Stonebridge Capital Advisors first reported a position in STJ in Q4 2013 and held it in 8 quarters. The position peaked at $313K in Q2 2016. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.

Stonebridge Capital Advisors reported no remaining St Jude Medical position as of Q4 2016 after selling out during the quarter.
Stonebridge Capital Advisors sold 2,914 St Jude Medical shares in Q4 2016, an estimated $232K.
Stonebridge Capital Advisors first reported a position in St Jude Medical in Q4 2013 and held it in 8 quarters.
Stonebridge Capital Advisors's St Jude Medical position peaked at $313K in Q2 2016.
551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2016, filed 15 Feb 2017.